Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer

DOI: 10.5306/wjco.v10.i5.201

Keywords: Ovarian cancer, Intraperitoneal chemotherapy, Community setting, Safety, Tolerability, Outcome

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text